Dynamics of resistance development to imatinib under increasing selection pressure: a combination of mathematical models and in vitro data. by Benjamin Werner, David Lutz, Tim H Brümmendorf, Arne Traulsen, Stefan Balabanov

Get full text

Peripheral blood CD3+HLADR+ cells and associated gut microbiome species predict response and overall survival to immune checkpoint blockade by Joao Gorgulho, Joao Gorgulho, Christoph Roderburg, Christoph Roderburg, Fabian Beier, Fabian Beier, Carsten Bokemeyer, Tim H. Brümmendorf, Tim H. Brümmendorf, Tom Luedde, Tom Luedde, Sven H. Loosen, Sven H. Loosen

Get full text

Transient elastography in adult patients with cryptic dyskeratosis congenita reveals subclinical liver fibrosis: a retrospective analysis of the Aachen telomere biology disease reg... by Mareike Tometten, Martin Kirschner, Susanne Isfort, Marie-Luise Berres, Tim H. Brümmendorf, Fabian Beier

Get full text

MicroRNA expression profiles of serum from patients before and after chemotherapy by Yvonne Diener, Thomas Walenda, Edgar Jost, Tim H. Brümmendorf, Andreas Bosio, Wolfgang Wagner, Ute Bissels

Get full text

PB1972: ASC4START: A PHASE IIIB, OPEN-LABEL, RANDOMIZED STUDY OF ASCIMINIB VERSUS NILOTINIB IN PATIENTS WITH NEWLY DIAGNOSED PH+ CHRONIC MYELOGENOUS LEUKEMIA IN CHRONIC PHASE by Andreas Hochhaus, Susanne Saussele, Francois-Xavier Mahon, Virginia Pilipovic, Yifan Zhang, Peter Schuld, Tim H Brümmendorf

Get full text

Tracking myeloid malignancies by targeted analysis of successive DNA methylation at neighboring CG dinucleotides by Monika Eipel, Tanja Božić, Anna Mies, Fabian Beier, Edgar Jost, Tim H. Brümmendorf, Uwe Platzbecker, Wolfgang Wagner

Get full text

Eltrombopag Preserves the Clonogenic Potential of Hematopoietic Stem Cells During Treatment With Antithymocyte Globulin in Patients With Aplastic Anemia by Margherita Vieri, Benjamin Rolles, Maria Crocioni, Mirle Schemionek-Reinders, Susanne Isfort, Jens Panse, Tim H. Brümmendorf, Fabian Beier

Get full text

Telomere Shortening in Peripheral Leukocytes Is Associated With Poor Survival in Cancer Patients Treated With Immune Checkpoint Inhibitor Therapy by Benjamin Rolles, Benjamin Rolles, Joao Gorgulho, Mareike Tometten, Mareike Tometten, Christoph Roderburg, Margherita Vieri, Margherita Vieri, Anne Abels, Anne Abels, Mihael Vucur, Felix Heymann, Frank Tacke, Tim H. Brümmendorf, Tim H. Brümmendorf, Tom Luedde, Fabian Beier, Fabian Beier, Sven H. Loosen

Get full text

DDX41 germline variants causing donor cell leukemia indicate a need for further genetic workup in the context of hematopoietic stem cell transplantation by Benjamin Rolles, Robert Meyer, Matthias Begemann, Miriam Elbracht, Edgar Jost, Matthias Stelljes, Ingo Kurth, Tim H. Brümmendorf, Gerda Silling

Get full text

Serum of myeloproliferative neoplasms stimulates hematopoietic stem and progenitor cells. by Richard K Lubberich, Thomas Walenda, Tamme W Goecke, Klaus Strathmann, Susanne Isfort, Tim H Brümmendorf, Steffen Koschmieder, Wolfgang Wagner

Get full text

Effective treatment of advanced Hodgkin lymphoma with a modified BEACOPP regimen for a patient with demyelinating hereditary motor and sensory neuropathy type 1 (HMSN1) by Patrick P. Hess, Monica S. Ventura Ferreira, Benjamin Rolles, Martin Kirschner, Florian Holtbernd, Mareike Tometten, Tim H. Brümmendorf, Fabian Beier

Get full text

Revesz syndrome revisited by Michael Karremann, Eva Neumaier-Probst, Frank Schlichtenbrede, Fabian Beier, Tim H. Brümmendorf, Friedrich W. Cremer, Peter Bader, Matthias Dürken

Get full text

Reconstructing the in vivo dynamics of hematopoietic stem cells from telomere length distributions by Benjamin Werner, Fabian Beier, Sebastian Hummel, Stefan Balabanov, Lisa Lassay, Thorsten Orlikowsky, David Dingli, Tim H Brümmendorf, Arne Traulsen

Get full text

PB1966: THE EFFECT OF BODY MASS INDEX ON THE SAFETY OF BOSUTINIB IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA: A POST HOC POOLED DATA ANALYSIS by Susanne Isfort, Carlo Gambacorti-Passerini, Tim H Brümmendorf, B. Douglas Smith, Simon Purcell, Huadong Zhao, Luke Kuttschreuter, Jane Apperley

Get full text

Combined inhibition of BCR-ABL1 and the proteasome as a potential novel therapeutic approach in BCR-ABL positive acute lymphoblastic leukemia. by Saskia Maletzke, Azam Salimi, Margherita Vieri, Kema Marlen Schroeder, Mirle Schemionek, Behzad Kharabi Masouleh, Tim H Brümmendorf, Steffen Koschmieder, Iris Appelmann

Get full text

Combined inhibition of BCR-ABL1 and the proteasome as a potential novel therapeutic approach in BCR-ABL positive acute lymphoblastic leukemia by Saskia Maletzke, Azam Salimi, Margherita Vieri, Kema Marlen Schroeder, Mirle Schemionek, Behzad Kharabi Masouleh, Tim H. Brümmendorf, Steffen Koschmieder, Iris Appelmann

Get full text

Cross-intolerance with bosutinib after prior tyrosine kinase inhibitors for Philadelphia chromosome-positive leukemia: long-term analysis of a phase I/II study by Jorge E. Cortes, Jeff H. Lipton, Vamsi Kota, Fausto Castagnetti, Sarit Assouline, Tim H. Brümmendorf, Eric Leip, Andrea Viqueira, Carlo Gambacorti-Passerini

Get full text

Novel homozygous nonsense mutation in the P5′N‐1 coding gene as an alternative cause for hereditary anemia with basophilic stippling by Martin Kirschner, Inga Rebecca Heinen, Steffen Koschmieder, Licinio Manco, Celeste Bento, Thomas Eggermann, Ingo Kurth, Edgar Jost, Tim H. Brümmendorf, Roland Fuchs

Get full text

P1365: HUMAN CD117 AS AN IMMUNOTHERAPEUTIC TARGET IN PRECLINICAL MODELS OF ADVANCED SYSTEMIC MASTOCYTOSIS by Anne Kaiser, Renier Myburgh, Laura Volta, Christian Pellegrino, Veronika Lysenko, Alexandre Theocharides, Tim H Brümmendorf, Marcelo A.S. de Toledo, Martin Zenke, Markus Manz

Get full text

MicroRNAs and Metabolites in Serum Change after Chemotherapy: Impact on Hematopoietic Stem and Progenitor Cells. by Thomas Walenda, Yvonne Diener, Edgar Jost, Elizabeth Morin-Kensicki, Tamme W Goecke, Andreas Bosio, Björn Rath, Tim H Brümmendorf, Ute Bissels, Wolfgang Wagner

Get full text